Bicycle Therapeutics PLC
NASDAQ:BCYC

Watchlist Manager
Bicycle Therapeutics PLC Logo
Bicycle Therapeutics PLC
NASDAQ:BCYC
Watchlist
Price: 23.22 USD -0.85% Market Closed
Market Cap: 1.6B USD
Have any thoughts about
Bicycle Therapeutics PLC?
Write Note

Bicycle Therapeutics PLC
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bicycle Therapeutics PLC
Operating Income Peer Comparison

Comparables:
CNTA
EXAI
AUTL
IMCR
GNS

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Bicycle Therapeutics PLC
NASDAQ:BCYC
Operating Income
-$196.5m
CAGR 3-Years
-45%
CAGR 5-Years
-46%
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Operating Income
-$171.3m
CAGR 3-Years
-154%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Exscientia PLC
NASDAQ:EXAI
Operating Income
-ÂŁ174.5m
CAGR 3-Years
-80%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Operating Income
-$175.5m
CAGR 3-Years
-1%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Operating Income
-ÂŁ59.6m
CAGR 3-Years
13%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Operating Income
ÂŁ54.2m
CAGR 3-Years
-4%
CAGR 5-Years
3%
CAGR 10-Years
4%

See Also

What is Bicycle Therapeutics PLC's Operating Income?
Operating Income
-196.5m USD

Based on the financial report for Sep 30, 2024, Bicycle Therapeutics PLC's Operating Income amounts to -196.5m USD.

What is Bicycle Therapeutics PLC's Operating Income growth rate?
Operating Income CAGR 5Y
-46%

Over the last year, the Operating Income growth was -18%. The average annual Operating Income growth rates for Bicycle Therapeutics PLC have been -45% over the past three years , -46% over the past five years .

Back to Top